- Home
- KURA vs ALRS Comparison
KURA vs ALRS Comparison
Compare KURA & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | ALRS |
|---|---|---|
| Founded | 2014 | 1879 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 912.7M | 810.6M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KURA | ALRS |
|---|---|---|
| Price | $8.08 | $34.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 5 |
| Target Price | $31.85 | ★ $36.40 |
| AVG Volume (30 Days) | ★ 1.6M | 119.7K |
| Earning Date | 11-10-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 2.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.70 |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $42.98 | $7.84 |
| Revenue Next Year | $116.68 | $2.83 |
| P/E Ratio | ★ N/A | $20.14 |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $7.36 | $20.76 |
| 52 Week High | $13.90 | $34.73 |
Technical Indicators
Market Signals| Indicator | KURA | ALRS |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 69.86 |
| Support Level | $8.65 | $32.22 |
| Resistance Level | $11.32 | N/A |
| Average True Range (ATR) | 0.54 | 0.80 |
| MACD | 0.08 | 0.36 |
| Stochastic Oscillator | 46.95 | 90.79 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About ALRS Alerus Financial Corporation
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and others. The company provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services and wealth management services, including retirement plans, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.